We now successfully identified a human BC cell line with an endogenous, placenta-like high expression of BCAR4. This cell line, IPH-926, had been established from an endocrine-resistant lobular BC and can be considered as the physiologic counterpart of the genetically engineered ZR-75-1-BCAR4 cell model. This evidence concerns the gene BCAR4 and breast cancer.